Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
Medical Imaging and Diagnostic Innovations
View Registrations Tell a Friend About This EventTell a Friend
 

Medical Imaging and Diagnostic Innovations - What's New In Imaging

3/6/2019
When: Mar 6, 2019
5:30-8:30 PM
Where: Regis College, Fine Arts Center
235 Wellesley St
Weston, Massachusetts  02493
United States
Contact: Bill Munger
617-620-4161


Online registration is closed.
« Go to Upcoming Event List  

Mar 6 Wed - MDG Boston FORUM
Life Saving Medical Imaging 
and Diagnostic Innovations
  • 3-D mammography finds malignant tumors hiding behind milk ducts
  • Ultrasonic echocardiography spots coronary artery plaques before they break and kill you 
  • High resolution digital imaging inside the kidney sees stones and aids their removal
  • Thermo Acoustic Enhanced Ultrasound detects Non-Alcoholic Fatty Liver Disease early
These advances in medical imaging
  • Reduce the need for some surgeries
  • Reduce false negatives to save lives
  • Reduce the total cost of care.
Program Description  

Mammography has dramatically reduced breast cancer mortality since becoming a recommended routine health screening. However, conventional 2D mammography missed many cancers in breasts with little radiolucent fat (dense breasts). It also required workups in women without disease.

3-D imaging in the human body, with CT and MRI, is a well-established method of medical imaging, but is expensive and produces a much higher radiation dose than the new 3D mammography (breast tomosynthesis) methods.

Multiple clinical trials of 3D breast imaging demonstrated improved cancer detection, especially in denser breasts, while also reducing the false positive workups needed in women without disease. Andrew Smith, PhD, VP of R&D, Breast Health Division of Hologic, will discuss the science, technology, and clinical advantages of their 3-D breast imaging technology.
   
Increased use of catheter-based approaches in diagnosing and treating heart disease have increased demand for improved ultrasonic imaging techniques, such as locating the imaging device in the esophagus adjacent to the heart.
Developed at Philips and tested at the Cardiovascular Division of Brigham and Women's Hospital in Boston, transesophageal and transthoracic echocardiography are compared clinically by Alexandra Goncalves, MD, PhD, Senior Medical Director, Cardiology Ultrasound, Philips Healthcare.
   
Boston Scientific is eliminating the operational inefficiencies and cost of reusable ureteroscopes, with LithoVue, a single-use digital flexible ureteroscope. LithoVue delivers detailed high resolution digital images for high quality visualization and navigation - to help urologists remove stones quickly, easily, safely and affordably.
Sarah Foley manages the Visualization R&D team in the Urology and Pelvic Health division at Boston Scientific developing new visualization techniques.
   
By detecting tiny pressure changes deep within tissues, ENDRA's Thermo Acoustic Enhanced Ultrasound (TAEUS) will enable clinicians to visualize tissue composition, function and temperature in ways previously possible only on CT & MRI -- at 50X lower cost, at the point of care with existing ultrasound equipment, all without using ionizing radiation or contrast agents. ENDRA CEO Francois Michelon, took the company through a 2017 IPO and secured a strategic partnership with GE Healthcare.
 
Images provided courtesy of HOLOGIC, Inc. and affiliates
Wednesday
March 6, 5:30 - 8:30 PM
Regis College Fine Arts Center
Weston, MA
 
Early-bird Forum Fees (by Feb 27)  
 Member/Alliance Partner - $30     
   Non-member - $45  
   Student (member) - $10
   Student (non-member) - $15
Gold Member - No Charge
     
     Event Sponsorship - $500  
 (Contact Hank Allard for details -hallard@mdgboston.org) 
 
Event Sponsors
    
  
 
 
 
 
 
Premier Annual Sponsors
    
 

 

  

 
 
Come join us for  
an exciting evening  
of science and hope!
 

Who Should Attend: 
  • Engineers, Entrepreneurs, and Innovators who are filling the gaps in the unmet needs
    of clinicians for medical diagnostics through imaging
  • Managers and investors seeking opportunities in emerging medical imaging technology.
Our Distinguished Panel
 
Sarah Foley, MS
Manager, Visualization R&D Team Urology and Pelvic
Health Division
Boston Scientific
Alexandra Goncalves, MD, PhD, MMSc, FESC
Senior Medical Director,
Cardiology Ultrasound
Philips Healthcare
Francois Michelon
CEO & Board Chair
ENDRA Life Sciences
Andrew Smith, PhD 
Vice President of R&D BreastHealth Division Hologic 
Jerry Shapiro, PhD MODERATOR
President and CEO
FEM-Medical,
Pres. Floelle, Inc.
MDG Boston BOD
Panel Bios
 
Sarah Foley, MS
Manager, Visualization R&D Team Urology and Pelvic Health Division, Boston Scientific
Sarah Foley manages an R&D team in developing new visualization products to treat stone disease and co-leads a cross-functional franchise team that is responsible for the execution of the Visualization portfolio strategy. She has 10+ years of experience leading cross functional teams in design and development of leading edge products across the Aerospace, Energy and Medical Device industries. She worked on programs across the product lifecycle, from requirements development and system design to testing and verification.

Alexandra Goncalves, MD, PhD, MMSc, FESC
Senior Medical Director, Cardiology Ultrasound Philips Healthcare
Dr. Goncalves leads the evaluation of key medical trends for the Cardiology Business within the Ultrasound Business Group. She provides leadership and guidance on the design, implementation, monitoring and interpretation of clinical evaluations, including testing of new developments. In addition, she provides insights on the diagnostic potential of various clinical opportunities in the context of clinical and regulatory dynamics from a global perspective. She partners with clinical, scientific, regulatory and marketing leaders around the globe. Dr. Goncalves is a world-renowned expert in echocardiography. Her past experience includes research in epidemiology and new clinical applications for echocardiography in the Cardiovascular Department at Brigham & Women's Hospital / Harvard Medical School.

Francois Michelon, MBA
CEO & Board Chair at ENDRA Life Sciences
Mr. Michelon has 20 years of healthcare technology start-up, private-equity and Fortune 20 experience, spanning diagnostic imaging, surgical equipment, orthopedic and dental sectors. He has expertise in raising capital in the private and public markets, and building businesses across capital products, implantable devices and services. ENDRA's Thermo Acoustic Enhanced Ultrasound (TAEUS) will enable clinicians to visualize tissue composition, function and temperature in ways previously possible only on CT & MRI -- at 50X lower cost, at the point of care. ENDRA's first clinical application targets early detection of Non-Alcoholic Fatty Liver Disease (NAFLD), affecting over 1 billion people globally.
 
Andrew Smith, PhD  
Vice President of R&D Breast Health Division of Hologic
Andy Smith has been involved in medical imaging research and development for over 30 years, with a current focus on advanced breast imaging technologies such as tomosynthesis. He lectures widely around the world on breast imaging and physics, and is a co-author on over 50 patents and patent applications. Prior to Hologic he was VP and a co-founder of Digital Scintigraphics, a company that developed and sold high resolution nuclear medicine neuroimaging systems. He received his BS and PhD degrees in physics from MIT.

Jerry Shapiro, PhD MODERATOR
President and CEO FEM-Medical, Pres. Floelle, Inc. MDG Boston Board Member
Dr. Shapiro was the first person at Boston University with an earned doctorate in Bioengineering, cofounder of their Department of Biomedical Engineering, Principal Investigator on many NIH grants, Director of two laboratories in glaucoma and ocular physiology and held the positions of Research Scientist, and Associate Professor of Surgery, Medicine, Ophthalmology and Biomedical Engineering.
 
Co-Champions
   
Jerry Shapiro, PhD 
President & CEO FEM-Medical,
President, Floelle, Inc.
MDG Boston Board Member
 
 
Andrea Cahill 
Electrical Engineer
Boston Scientific
MDG Boston Board Member
Fees -  (Light dinner included)
Fee Category Early Registration
(By Feb 27)
Week Prior
(Feb 27 - Mar 6)

At the Door
(Mar 6
 
Member/Alliance Partner: $30 $35 $45
Non-Member: $45 $55 $65
Student Member $10 $12 $15    
Student Non-member w/ a valid ID $15 $18 $20 
Gold Member No Charge No Charge  No Charge 
 
      
Event Sponsor - $500 -  (Contact Hank Allard for details - hallard@mdgboston.org)
    
  
About MDG
The premier MedTech community advancing healthcare  
by enabling diverse professionals to grow through  
expert forums, collaboration, and knowledge sharing.
 
The Medical Development Group (MDG) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care. MDG pursues this mission through the organization of educational programs and forums: the facilitation of cross-disciplinary dialogue and collaboration; the creation of venues for networking and information sharing for current and aspiring professionals, clinicians, and entrepreneurs; and the development of alliances with complementary organizations.

more MDG Calendar

12/4/2019
Cutting Edge Advances in Auditory Device Therapies

12/19/2019
Annual Holiday Party

1/8/2020
Software as a Medical Device (SaMD)

MDG Premium & Annual Sponsors

 CONTACT


 Medical Development  Group
 POB 555
 Concord, MA 01742

 

 Email:

 MDGBoston@gmail.com

 NAVIGATION 

 

Home

  

 About Us
 Terms of Use
 Privacy Policy

PREMIUM SPONSOR

 

  

PREMIUM SPONSOR

 

 



Association Management Software Powered by YourMembership  ::  Legal